Effect of Food on the Pharmacokinetics of YH4808, a Potassium-Competitive Acid Blocker, after Single- and Multiple-Oral Dosing in Healthy Subjects

PurposeYH4808 is a potassium-competitive acid blocker, developed for the treatment of acid-related disorders. Two clinical studies in healthy male subjects were conducted to evaluate the effect of food on the pharmacokinetics of YH4808.MethodsThe first study, a randomized, three-treatment, three-period, crossover study, compared pharmacokinetics of YH4808 (300mg) after a single dose at fed state with a standard or a high-fat meal to those at fasted state. The second study, a randomized, two-treatment, two-period, crossover study, investigated pharmacokinetics at fasted or fed state with a standard meal after twice daily dose of YH4808 (100mg) for 7days. Bloods for pharmacokinetic evaluation were sampled up to 48h post-dose and 24h post-dose at steady state, respectively. The pharmacokinetic parameters were estimated by non-compartmental method.ResultsAfter single dosing, the geometric means of maximum plasma concentration increased by 1.2 and 2.1 times in the fed states with a standard meal and a high-fat meal, respectively, of that in fasted state. Corresponding values of area under the plasma concentration-time curve (AUC) from time 0 to the last measurable time point increased by 1.8 and 2.8 times, respectively. After multiple dosing, the geometric mean for 24-h AUC at steady state slightly increased in fed state by 1.1 times of that in fasted state.ConclusionsAs fat content of the food increased, the systemic exposure of YH4808 after single dosing increased. However, systemic exposures at steady state after multiple dosing between fasted and fed states were similar.Trial registrationClinicalTrials.gov registry no.: NCT01520012